PMC Articles for MedGen (Select 1737009) - PMC

Result Filters

Links from MedGen

Items: 1 to 20 of 22

<< First< Prev

Page of 2

Select item 109924551.

Effectiveness and safety of radiotherapy plus programmed death-1 inhibitors and lenvatinib in patients with advanced biliary tract carcinoma: a real-world study

Yunchao Wang, Xiaobo Yang, Yanyu Wang, Jingnan Xue, Nan Zhang, Xu Yang, Ning Cong, Junwei Zhang, Chengpei Zhu, Longhao Zhang, Xiaorong Hou, Haitao Zhao

Cancer Immunol Immunother. 2023 Jul; 72(7): 2197–2204. Published online 2023 Mar 1. doi: 10.1007/s00262-023-03399-2

PMCID:: PMC10992455

Abstract Article PDF–816K

Select item 101864972.

A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line treatment of advanced biliary tract carcinoma

Jie Zeng, Jie Ma, Zhiming Zeng, Lihua Yang, Yanfeng Jiang, Ning Mo, Fuchao Ma, Cuizhen Liu, Rong Li, Jing Tang, Shanyu Qin, Haixing Jiang

J Gastrointest Oncol. 2023 Apr 29; 14(2): 758–767. Published online 2023 Apr 26. doi: 10.21037/jgo-23-218

PMCID:: PMC10186497

Abstract Article PDF–319K

Select item 89284593.

Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma

Yunchao Wang, Xiaobo Yang, Dongxu Wang, Xu Yang, Yanyu Wang, Junyu Long, Jinxue Zhou, Zhenhui Lu, Yilei Mao, Xinting Sang, Mei Guan, Haitao Zhao

Front Oncol. 2022; 12: 785535. Published online 2022 Mar 3. doi: 10.3389/fonc.2022.785535

PMCID:: PMC8928459

Abstract Article PDF–1.3M

Select item 89144874.

A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma

Cecilia Monge, Erica C Pehrsson, Changqing Xie, Austin G Duffy, Donna Mabry, Bradford J Wood, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Anuradha Budhu, Sophie Wang, Mayank Tandon, Lichun Ma, Xin Wei Wang, Tim F Greten

Oncologist. 2022 Mar; 27(3): e273–e285. Published online 2022 Feb 19. doi: 10.1093/oncolo/oyab073

PMCID:: PMC8914487

Abstract Article PDF–24M

Select item 85073235.

Efficacy and Safety of First-Line Chemotherapies for Patients With Advanced Biliary Tract Carcinoma: A Systematic Review and Network Meta-Analysis

Yanfeng Jiang, Zhiming Zeng, Jie Zeng, Cuizhen Liu, Jinfeng Qiu, Ye Li, Jing Tang, Ning Mo, Lihua Du, Jie Ma

Front Oncol. 2021; 11: 736113. Published online 2021 Sep 28. doi: 10.3389/fonc.2021.736113

PMCID:: PMC8507323

Abstract Article PDF–5.1M

Select item 75199226.

Systemic treatment options for advanced biliary tract carcinoma

Changqing Xie, Nicole A. McGrath, Cecilia Monge Bonilla, Jianyang Fu

J Gastroenterol. 2020; 55(10): 944–957. Published online 2020 Aug 3. doi: 10.1007/s00535-020-01712-9

PMCID:: PMC7519922

Abstract Article PDF–523K

Select item 60569807.

Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis

Jun Ho Ji, Young Saing Kim, Inkeun Park, Soon Il Lee, Rock Bum Kim, Joon Oh Park, Sung Yong Oh, In Gyu Hwang, Joung-Soon Jang, Haa-Na Song, Jung-Hun Kang

Cancer Res Treat. 2018 Jul; 50(3): 791–800. Published online 2017 Aug 23. doi: 10.4143/crt.2017.044

PMCID:: PMC6056980

Abstract Article PDF–587K

Select item 53708158.

Chemotherapy for advanced biliary tract carcinoma: A meta-analysis of randomized controlled trials

Lawrence Chen, Chiehfeng Chen, Yun Yen, Ka-Wai Tam

Medicine (Baltimore) 2016 Aug; 95(33): e4584. Published online 2016 Aug 19. doi: 10.1097/MD.0000000000004584

PMCID:: PMC5370815

Abstract Article PDF–426K

Select item 43260549.

Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades

Susanna V Ulahannan, Osama E Rahma, Austin G Duffy, Oxana V Makarova-Rusher, Metin Kurtoglu, David J Liewehr, Seth M Steinberg, Tim F Greten

Hepat Oncol. 2015 Jan; 2(1): 39–50. Published online 2015 Jan 12. doi: 10.2217/hep.14.36

PMCID:: PMC4326054

Abstract Article PDF–1.6M

Select item 351368810.

Safety and long term efficacy of porfimer sodium photodynamic therapy in locally advanced biliary tract carcinoma

Stephen P Pereira, Guruprasad P Aithal, Krish Ragunath, John Devlin, Faye Owen, Helen Meadows

Photodiagnosis Photodyn Ther. Author manuscript; available in PMC 2013 Dec 1.

Published in final edited form as: Photodiagnosis Photodyn Ther. 2012 Dec; 9(4): 287–292. Published online 2012 Aug 30. doi: 10.1016/j.pdpdt.2012.03.005

PMCID:: PMC3513688

Abstract Article PDF–1.3M

Select item 281374611.

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

C Bengala, F Bertolini, N Malavasi, C Boni, E Aitini, C Dealis, S Zironi, R Depenni, A Fontana, C Del Giovane, G Luppi, P Conte

Br J Cancer. 2010 Jan 5; 102(1): 68–72. Published online 2009 Nov 24. doi: 10.1038/sj.bjc.6605458

PMCID:: PMC2813746

Abstract Article PDF–266K

Select item 253874812.

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

T André, J M Reyes-Vidal, L Fartoux, P Ross, M Leslie, O Rosmorduc, M R Clemens, C Louvet, N Perez, F Mehmud, W Scheithauer

Br J Cancer. 2008 Sep 16; 99(6): 862–867. Published online 2008 Aug 26. doi: 10.1038/sj.bjc.6604628

PMCID:: PMC2538748

Abstract Article PDF–135K

Select item 236011113.

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials

F Eckel, R M Schmid

Br J Cancer. 2007 Mar 26; 96(6): 896–902. Published online 2007 Feb 27. doi: 10.1038/sj.bjc.6603648

PMCID:: PMC2360111

Abstract Article PDF–185K

Select item 148389714.

A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma

Kazuma Kobayashi, Akihito Tsuji, Sojiro Morita, Tadashi Horimi, Tetsuhiko Shirasaka, Takashi Kanematsu

BMC Cancer. 2006; 6: 121. Published online 2006 May 6. doi: 10.1186/1471-2407-6-121

PMCID:: PMC1483897

Abstract Article PDF–585K

Select item 1090497915.

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma

Cecilia Monge, Changqing Xie, Yuta Myojin, Kelley L. Coffman‐D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D. Figg, Maggie Cam, Richard Finney, Elliot B. Levy, David E. Kleiner, Seth M. Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J. Wood, Tim F. Greten

Cancer Med. 2024 Feb; 13(3): e6912. Published online 2024 Jan 11. doi: 10.1002/cam4.6912

PMCID:: PMC10904979

Abstract Article PDF–2.9M

Select item 1046971316.

Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma

Yunfeng Li, Chaochao Tan, Xinmin Yin, Siwei Zhu, Rongyao Cai, Chunhong Liao, Yifei Wu, Qihong Zeng, Chengzhi Cai, Wang Xie, Xiangyu He, Hao‐quan Wen, Guomin Lin, Qingqing He, Tingting He, Peng Gu, Chang‐jun Liu

Cancer Med. 2023 Aug; 12(15): 16076–16086. Published online 2023 Jun 21. doi: 10.1002/cam4.6261